Intellia Therapeutics
NTLA
NTLA
291 hedge funds and large institutions have $2.68B invested in Intellia Therapeutics in 2023 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 122 increasing their positions, 77 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
291
Holders Change
+8
Holders Change %
+2.83%
% of All Funds
4.27%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
48
Increased
122
Reduced
77
Closed
36
Calls
$21.1M
Puts
$30.2M
Net Calls
-$9.1M
Net Calls Change
-$9.67M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$155M |
| 2 |
AIM
2
ARK Investment Management
St. Petersburg,
Florida
|
$348M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$144M |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$27.2M |
| 5 |
5
BlackRock
New York
|
$275M |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$38.4M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$36.2M |
| 3 |
AG
3
Artal Group
Luxembourg
|
$0 |
| 4 |
4
Millennium Management
New York
|
$0 |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$16.3M |
